NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Omeros Corporation Share Price Chart

O H L

Omeros Corporation Performance Overview

Days Range
$18.10Low
$18.63High

Markets Today

Previous Close$18.45
Open$18.63
Volume215,478
Day's Range$18.10 - $18.63
52W Range$3.94 - $19.65
Market Cap$1.26 B

Historical Performance

1M Returns+7.33
3M Returns+79.47
6M Returns+68.49
1Y Returns+333.10
5Y Returns+15.46
10Y Returns+62.70

Omeros Corporation Fundamentals

Market Cap$1.26 B
Dividend yield0.00
PE Ratio11.97
PEG RatioN/A
Revenue$0.00
ROE TTMN/A
EPS TTM$1.45
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-121.83 M
Profit MarginN/A
Market Cap$1.26 B
Dividend yield0.00
PE Ratio11.97
PEG RatioN/A
Revenue$0.00
ROE TTMN/A
EPS TTM$1.45
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-121.83 M
Profit MarginN/A

Omeros Corporation Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$9.89 M$28.53 M
Gross Profit +$0$0$0$0$9.31 M$27.73 M
Operating Income -$34.97 M-$32.35 M-$26.39 M-$29.08 M-$17.42 M$74.00 K
EBITDA -$34.68 M-$32.15 M-$26.15 M-$28.85 M-$17.18 M$267.00 K
Interest Expense -$3.65 M-$15.00 K$13.36 M-$8.73 M-$5.89 M-$7.58 M
Depreciation $289.00 K$200.00 K$240.00 K$235.00 K$239.00 K$193.00 K
Income Before Tax -$37.56 M-$25.89 M-$21.24 M$81.90 M$51.31 M$6.67 M
Income Tax Expense $0$0$0$2.01 M$57.00 K$29.00 K
Net Income +-$33.46 M-$25.42 M-$30.92 M$86.45 M$56.06 M$13.23 M
Net Profit Margin ----566.66%46.38%

Omeros Corporation Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $580.00 K$599.00 K$700.00 K$716.00 K$720.00 K$721.00 K
Reserve & Surplus -$943.80 M-$969.23 M-$1.00 B-$913.70 M-$857.63 M-$844.40 M
Non-Current Liabilities $365.49 M$343.75 M$325.43 M$368.80 M$290.06 M$243.22 M
Current Liabilities $83.22 M$85.50 M$80.76 M$78.06 M$59.44 M$94.96 M
Total Liabilities $448.71 M$429.25 M$406.18 M$446.86 M$349.51 M$338.18 M
Fixed Assets $2.42 M$2.24 M$2.01 M$1.77 M$1.53 M$1.38 M
Current Assets $96.18 M$69.65 M$71.81 M$215.67 M$180.35 M$185.24 M
Total Assets $235.16 M$200.57 M$185.71 M$325.63 M$286.17 M$286.83 M

Omeros Corporation Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$33.46 M-$25.42 M-$30.92 M$86.45 M$56.06 M$13.23 M
Operating Cash Flow -$35.84 M-$21.94 M-$18.47 M-$39.84 M-$14.51 M$4.15 M
Investing Cash Flow $38.54 M$21.30 M-$6.86 M$111.55 M$28.73 M$3.40 M
Financing Cash Flow -$1.84 M-$1.72 M$25.82 M-$64.44 M-$21.98 M-$7.47 M
Change in Cash $861.00 K-$2.36 M$491.00 K$7.26 M-$7.75 M$82.00 K

Omeros Corporation Return Calculator

The Omeros Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$11,377
Invested Amount$10,000
Est. Returns$1,377
Invest in USA Stock Today

About Omeros Corporation

Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.

FAQs

Omeros Corporation (OMER) share price as of September 18, 2026 is $18.18. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Omeros Corporation (OMER) Share by opening an international trading account with Angel One.
Purchasing Omeros Corporation (OMER) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Omeros Corporation (OMER) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Omeros Corporation (OMER) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Omeros Corporation on September 18, 2026, is $1.26 B.
Omeros Corporation operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Omeros Corporation (OMER) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91